Thierry CRESTEIL

Dr. Thierry CRESTEIL


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2017 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
SMSerge Mignani
Serge Mignani
NBNabil El Brahmi
Nabil El Brahmi
LELaure Eloy
Laure Eloy
JPJoel Poupon
Joel Poupon
VNValérie Nicolas
Valérie Nicolas
TCThierry CRESTEIL
Thierry CRESTEIL

9 October 2017 in Molecular Pharmaceutics
Verified
Journal Article
Open access
SMSerge Mignani
Serge Mignani
NBNabil El Brahmi
Nabil El Brahmi
SKSaïd El Kazzouli
Saïd El Kazzouli
RLRegis Laurent
Regis Laurent
SLSonia Ladeira
Sonia Ladeira
JMJean-Pierre Majoral
Jean-Pierre Majoral
Original metallophosphorus dendrimers (generation 3, 48 terminal groups) have been prepared via the complexation of phosphorus dendrimers bearing imino-pyridino end groups with Au(III) or with both Au(III) and Cu(II). The complexation of the dendrimer with Au(III), leading to 1G3-[Au48][AuCl4]48, strongly increased the antiproliferative activities against both KB and HL-60 tumoral cell lines, showing IC50s in the low nanomolar range. It can be noticed also that this gold conjugated phosphorus dendrimer displayed low activity on the quiescent cell line EPC versus its potent antiproliferative activity against actively dividing cells. In order to evaluate the potential synergistic effect between Au(III) and Cu(II) and the influence of the number of Au(III) moieties on the surface of dendrimer against the proliferative activities, nine other original dendrimers with several surface modifications have been prepared. Whatever the number of Au(III) moieties introduced on the surface of dendrimers, all the dendrimers prepared displayed similar potency (nanomolar range) to 1G3-[Au48][AuCl4]48 against KB and HL60. In marked contrast synergistic effects on the antimicrobial activity of some of these phosphorus dendrimers are observed when both Au(III) and Cu(II) are present on the dendritic structure.

1 October 2016 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
SMSerge Mignani
Serge Mignani
NBNabil El Brahmi
Nabil El Brahmi
SKSaïd El Kazzouli
Saïd El Kazzouli
LELaure Eloy
Laure Eloy
DCDelphine Courilleau
Delphine Courilleau
JMJean-Pierre Majoral
Jean-Pierre Majoral

1 July 2018 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
ADAmel Djehal
Amel Djehal
MKMohammad Krayem
Mohammad Krayem
Ahmad NajemAhmad Najem
Ahmad Najem
HHHassan Hammoud
Hassan Hammoud
TCThierry CRESTEIL
Thierry CRESTEIL
Laurent DesaubryLaurent Desaubry
Laurent Desaubry

22 February 2016 in BMC Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
HAHuguette Agnaniet
Huguette Agnaniet
EMElvis Jolinom Mbot
Elvis Jolinom Mbot
OKOusmane Keita
Ousmane Keita
JFJean-alain Fehrentz
Jean-alain Fehrentz
AAAnita Ankli
Anita Ankli
CMChantal Menut
Chantal Menut
Diabetes mellitus is a metabolic disorder which is rising globally in rich and developing countries. In the African region this rate is the highest, with 20 million diagnosed diabetics. Despite a noticeable progress in the treatment of diabetes mellitus by synthetic drugs, the search for new natural anti-diabetic agents is going on. Nauclea diderrichii (De Wild.) Merr. (ND) and Sarcocephalus pobeguinii Hua ex Pellegr. (SP) are used as traditional medicines in Gabon for the treatment of different diseases, especially in the case of diabetes. The aim of this study was to evaluate the antidiabetic potential of these two medicinal plants traditionally used in Gabon. Pharmacological (inhibitory action on α and β-glucosidases) and toxicological (effect on human T cell proliferation) studies were conducted on aqueous extracts of ND (leaves and bark) and SP (bark) collected in Gabon. All raw extracts were analyzed by HPTLC and their content in phenolic compounds was determined by using standard method. The most active extracts were submitted to preparative HPLC in order to evidence the most efficient subfractions by biological evaluation. The results showed that two extracts from ND were potent α-glucosidase inhibitors, the leaf extract being more active that the bark extract: the first one was more than 60 fold more active than Acarbose, which is an oral medication used to treat type 2 diabetes; the extract from SP bark was less efficient. The HPLC subfractions of the extracts of ND leaves and SP bark were tested in the same experimental conditions. In each case, the most active subfractions still show very potent inhibitory effect on α-glucosidase (80-90 % inhibition at 0.1 mg/mL). The most efficient extract, from ND leaves, was also characterized by the highest percentage of phenolic compounds, which suggests a relationship between its inhibitory potential on α-glucosidase and its content in phenolic compounds. Conversely, only a moderate inhibitory activity of the three extracts was observed on β-glucosidase. These results clearly indicated that active compounds present in N. diderrichii and S. pobeguinii leaves or/and bark were selective and highly potent inhibitors of α-glucosidase and validate their popular use for the treatment of diabetes.

1 February 2012 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Closed access
GLGuy Lewin
Guy Lewin
GAGeneviève Aubert
Geneviève Aubert
STSylviane Thoret
Sylviane Thoret
JDJoelle Dubois
Joelle Dubois
TCThierry CRESTEIL
Thierry CRESTEIL